首页 | 本学科首页   官方微博 | 高级检索  
检索        

系统性红斑狼疮并发感染的流行病学研究
引用本文:董光富,叶任高,张晓,陈文莉.系统性红斑狼疮并发感染的流行病学研究[J].中华医院感染学杂志,2004,14(7):755-758.
作者姓名:董光富  叶任高  张晓  陈文莉
作者单位:1. 广东省人民医院,广东,广州,510080
2. 中山大学第一医院,广东,广州,510089
基金项目:中山医科大学 2 11工程重点科研基金资助(No9815 1)
摘    要:目的了解系统性红斑狼疮(SLE)患者并发感染的流行病学特征。方法前瞻性队列随访研究SLE患者门诊、住院及其随访,观察、记录并统计分析SLE患者的临床和实验室资料。结果371例SLE患者随访观察1年,211例患者(56.8%)发生341次感染(医院感染105次),其中99例患者发作≥2次感染,79例患者(37.4%)发生≥2种病原体的混合感染;检出细菌感染191次(56.0%),难治性条件致病菌明显增多,病毒感染102次(29.9%),真菌感染42次(12.3%),寄生虫类6次(1.8%);呼吸道及皮肤粘膜是本组SLE患者最常见感染部位;感染组较非感染组,平均住院日、SLEDAI、白细胞/淋巴细胞减少、尿蛋白水平、补体C3水平和1年死亡率差异显著;单因素Logistic回归分析显示SLEDAI>9、尿蛋白定量>2.0g/24h、MP冲击累积量>1.5g/疗程、CTX冲击量>1.5/月和平均激素日剂量>0.5mg/kg与SLE患者并发感染有明显相关性;多因素Logistic逐步回归分析显示,只有尿蛋白定量>2.0g/24h、MP冲击累积量>1.5g/疗程、CTX冲击量>1.5/月和平均激素日剂量>0.5mg/kg是SLE患者并发感染独立危险因素。结论SLE患者并发感染的致病菌主要为细菌感染,狼疮肾损害程度和免疫抑制治疗是引起SLE患者感染的独立危险因素。

关 键 词:系统性红斑狼疮  感染  流行病学
文章编号:1005-4529(2004)07-0755-04
修稿时间:2003年12月20

Epidemiology of Systemic Lupus Erythematosus Patients with Infection
DONG Guang-fu,YE Ren-gao,ZHANG Xiao,CHEN Wen-li.Epidemiology of Systemic Lupus Erythematosus Patients with Infection[J].Chinese Journal of Nosocomiology,2004,14(7):755-758.
Authors:DONG Guang-fu  YE Ren-gao  ZHANG Xiao  CHEN Wen-li
Institution:DONG Guang-fu~1,YE Ren-gao~2,ZHANG Xiao~1,CHEN Wen-li~1
Abstract:OBJECTIVE To know the epidemiologic characteristics of systemic lupus erythematosus (SLE) patients with infection. METHODS A prospective cohort study was used. RESULTS Of 371 cases of SLE patients followed with one year, there were 211 cases (56.8%) and 341 episodes of infections, 99 cases with two episodes of infections, 79 cases with two or more kinds of pathogens overlap infections. Checked pathogens included bacteria (191 episodes, 56%), viruses (102 episodes, 29.9%), fungi (42, 12.3% ) and others (1.8%). There was significant difference in mean hospital time, SLEDAI, leukopenia/lymphopenia, 24h urine protein level, complement C3 level and one year death rate between infected SLE patients and control ones. Univariate Logistic regressions showed SLEDAI >9, urine protein >2.0 g/24 h, IV methylprednisolone (MP) cumulative dose (>1.5 g/3 d,) IV CTX cumulative dose >1.5 g/m and mean prednisone dose >30 mg/d, respectively correlated with infection, but multivariate regressions showed only urine protein >2.0 g/24 h, IV methylprednisolone (MP) cumulative dose >1.5 g/3d, IV CTX cumulative dose >1.5 g/m and mean prednisone dose >30 mg/d were independent risk factors for infection in patients with SLE. CONCLUSIONS Bacteria are main infective pathogens, and the lupus nephritis and immunosuppressive drugs therapy are major risk factors.
Keywords:Systemic lupus erythematosus  Infection  Epidemiology
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号